|
rs11655237
|
LINC00511;LINC00673
|
Pancreatic carcinoma
|
|
0.720 |
GeneticVariation |
BEFREE |
Long noncoding RNA LINC00673 has been widely explored for its role in the development and prognosis of many tumors, and 2 genome-wide association studies identified that LINC00673 rs11655237 was associated with susceptibility to pancreatic cancer.
|
30286619 |
2019 |
|
rs11655237
|
LINC00511;LINC00673
|
Pancreatic carcinoma
|
|
0.720 |
GeneticVariation |
BEFREE |
<b>Background:</b> Two genome-wide association studies (GWASs) identified LINC00673 rs11655237 was associated with susceptibility to pancreatic cancer.
|
31118802 |
2019 |
|
rs11655237
|
LINC00511;LINC00673
|
Pancreatic carcinoma
|
T |
0.720 |
GeneticVariation |
GWASCAT |
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
|
26098869 |
2015 |
|
rs983318
|
LINC00511;LINC00673
|
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
|
rs983318
|
LINC00511;LINC00673
|
Adenocarcinoma of large intestine
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
|
rs983318
|
LINC00511;LINC00673
|
Colorectal Neoplasms
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
|
rs983318
|
LINC00511;LINC00673
|
Malignant tumor of colon
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
|
rs983318
|
LINC00511;LINC00673
|
Malignant neoplasm of large intestine
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
|
rs983318
|
LINC00511;LINC00673
|
Adenoma of large intestine
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
|
rs983318
|
LINC00511;LINC00673
|
Colorectal Carcinoma
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
|
rs983318
|
LINC00511;LINC00673
|
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
|
rs983318
|
LINC00511;LINC00673
|
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
|
rs983318
|
LINC00511;LINC00673
|
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
|
rs7214041
|
LINC00511;LINC00673
|
Pancreatic carcinoma
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
|
29422604 |
2018 |
|
rs11652463
|
LINC00511;LINC00673
|
Breast Carcinoma
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Association analysis identifies 65 new breast cancer risk loci.
|
29059683 |
2017 |
|
rs56868433
|
LINC00511;LINC00673
|
Serum albumin measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies multiple loci influencing human serum metabolite levels.
|
22286219 |
2012 |
|
rs11655237
|
LINC00511;LINC00673
|
Malignant Neoplasms
|
|
0.040 |
GeneticVariation |
BEFREE |
Previous genome-wide association studies have identified that the LINC00673 rs11655237 C>T polymorphism is associated with the risk of several types of cancer.
|
31257678 |
2019 |
|
rs11655237
|
LINC00511;LINC00673
|
Malignant Neoplasms
|
|
0.040 |
GeneticVariation |
BEFREE |
Expression of LINC00673 was significantly higher in adjacent normal tissues than in paired cancer tissues (<i>P</i><0.001) and significantly lower in the cancer or paired adjacent normal tissues of GC patients with rs11655237 allele A than in those with rs11655237 allele G (<i>P</i><0.001).
|
31118802 |
2019 |
|
rs11655237
|
LINC00511;LINC00673
|
Malignant Neoplasms
|
|
0.040 |
GeneticVariation |
BEFREE |
Expression of LINC00673 was significantly higher in adjacent normal tissues than in paired cancer tissues ( P < .01) and significantly lower in the cancer or paired adjacent normal tissues of patients with cervical cancer having rs11655237 allele A than in those having rs11655237 allele G ( P < .001).
|
30286619 |
2019 |
|
rs11655237
|
LINC00511;LINC00673
|
Malignant Neoplasms
|
|
0.040 |
GeneticVariation |
BEFREE |
Previous genome-wide association studies (GWASs) identified the <i>LINC00673</i> rs11655237 C>T polymorphism to be associated with the susceptibility of several malignant tumors.
|
29339420 |
2018 |
|
rs11655237
|
LINC00511;LINC00673
|
Primary malignant neoplasm
|
|
0.030 |
GeneticVariation |
BEFREE |
Expression of LINC00673 was significantly higher in adjacent normal tissues than in paired cancer tissues (<i>P</i><0.001) and significantly lower in the cancer or paired adjacent normal tissues of GC patients with rs11655237 allele A than in those with rs11655237 allele G (<i>P</i><0.001).
|
31118802 |
2019 |
|
rs11655237
|
LINC00511;LINC00673
|
Primary malignant neoplasm
|
|
0.030 |
GeneticVariation |
BEFREE |
Previous genome-wide association studies have identified that the LINC00673 rs11655237 C>T polymorphism is associated with the risk of several types of cancer.
|
31257678 |
2019 |
|
rs11655237
|
LINC00511;LINC00673
|
Primary malignant neoplasm
|
|
0.030 |
GeneticVariation |
BEFREE |
Expression of LINC00673 was significantly higher in adjacent normal tissues than in paired cancer tissues ( P < .01) and significantly lower in the cancer or paired adjacent normal tissues of patients with cervical cancer having rs11655237 allele A than in those having rs11655237 allele G ( P < .001).
|
30286619 |
2019 |
|
rs11655237
|
LINC00511;LINC00673
|
Neoplasms
|
|
0.020 |
GeneticVariation |
BEFREE |
Furthermore, stratified analysis indicated that rs11655237 T allele carriers in the following subgroups were more likely to develop HB: children older than 17 months, males, and those with tumors of clinical stages III + IV.
|
31178901 |
2019 |
|
rs11655237
|
LINC00511;LINC00673
|
Nephroblastoma
|
|
0.020 |
GeneticVariation |
BEFREE |
In conclusion, we failed to find any association between the LINC00673 rs11655237 C>T polymorphism and WT risk.
|
31257678 |
2019 |